Skip to main content
The World Allergy Organization Journal logoLink to The World Allergy Organization Journal
. 2026 Apr 17;19(5):101378. doi: 10.1016/j.waojou.2026.101378

Corrigendum to “Retrospective analysis of the efficacy and safety of 100 mg abrocitinib in patients with moderate to severe atopic dermatitis: Real-world study” [World Allergy Organ J 16 (2) (2023) 101167]☆

Maoying Li a, Cuihong Lian b,⁎, Xi Wang c
PMCID: PMC13098403  PMID: 42021979

The authors regret an error in the data presentation of 8 (Adverse Event Analysis) in the above-mentioned article. During the data processing stage, an operational error led to the duplication of data between two distinct comparison groups. Specifically, the data presented under the "A group" and "D group" columns (Medication background) were inadvertently copied from the "100 mg" and "200 mg" columns (Dosage of medication), which resulted in an incorrect representation of the patient distribution in the medication background categories.

The authors have now reviewed and corrected the data based on the original medical records. The corrected version of the table is presented below. All text descriptions, statistical interpretations, and the overall conclusions of the manuscript remain unaffected by this correction. The P-values have been reconfirmed and are consistent with the original findings.

Table 8.

(Corrected Version)

Adverse event
Totle
(n,%; N = 103)
Medication background
X2
P-value
Dosage of medication
X2
P-value
A group
(n,%; N = 168)
D group
(n,%; N = 96)
100 mg
(n,%; N = 235)
200 mg
(n,%; N = 29)
Nausea 37,14.0% 20,11.9% 17,17.7% 1.412 0.235 34,14.5% 3,10.3% 0.758 0.384
Acne-like eruptions 29,11.0% 16, 9.5% 13,13.5% 0.7581 0.384 25,10.6% 4,13.8% 0.411 0.521
Headache 18,6.8% 8, 4.8% 10,10.4% 1.802 0.179 17,7.2% 1,3.5% 1.684 0.194
Herpes simplex virus infection 6,2.3% 2,1.2% 4,4.2% 0.821 0.365 6,2.6% – – –
Elevated liver enzymes 5,1.9% 3,1.8% 2,2.1% 0.000 1.000 5,2.1% – – –
Dyslipidemia 4,1.5% 2,1.2% 2,2.1% 0.000 1.000 4,1.7% – – –
Upper Respiratory Infection 3,1.1% 1,0.6% 2,2.1% 0.000 1.000 2,0.9% 1,3.5% 0.255 0.614
Decrease in platelets 1,0.4% 1,0.6% – – – 1,0.4% – – –

The authors would like to express their apologies once again for the following error: In 8 of the original article, the data in the "Medication background" and "Dosage of medication" columns were duplicated. The correct data have now been updated. This error was limited to the table presentation and does not affect the research conclusions.

Footnotes

☆

Full list of author information is available at the end of the article.


Articles from The World Allergy Organization Journal are provided here courtesy of World Allergy Organization

RESOURCES